Viridian Therapeutics
-
Brokers
Brokers Set Expectations for Viridian Therapeutics, Inc.’s Q1 2024 Earnings (NASDAQ:VRDN)
Viridian Therapeutics, Inc. (NASDAQ:VRDN – Free Report) – Equities research analysts at Wedbush reduced their Q1 2024 earnings per share…
Read More »